0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Dattoli Cancer Foundation
a/k/a: PCRN
Address
2803 Fruitville Road
Sarasota, FL 34237
USA
Phone
941-365-5599
Fax
941-366-3786
800 Number
800-915-1001
TDD
--
Email Address
info@dattolifoundation.org
Website
http://www.dattolifoundation.org
The mission of the Dattoli Cancer Foundation, a non-profit organization, is to provide information regarding treatment options and to serve as a source of hope and encouragement for prostate cancer patients and their families. Established in 1995, the Network serves people throughout the United States, providing advocacy, patient networking, referrals and patient educational materials.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.
